🇨🇦 Combination (Bivalent) BNT162b2 and BNT162b2 OMI in Canada

Combination (Bivalent) BNT162b2 and BNT162b2 OMI (combination-bivalent-bnt162b2-and-bnt162b2-omi) regulatory status in Canada.

Marketing authorisation

Combination (Bivalent) BNT162b2 and BNT162b2 OMI in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Canada

Frequently asked questions

Is Combination (Bivalent) BNT162b2 and BNT162b2 OMI approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Combination (Bivalent) BNT162b2 and BNT162b2 OMI in Canada?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.